Respiratory Syncytial Virus Infection in Infants
📧 Sign up to get email alerts when something new happens for Respiratory Syncytial Virus Infection in Infants.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-08-27Clinical Trial Update: A Study to Evaluate a Single Intravenous Dose of Motavizumab for the Treatment of Children Hospitalized With Respiratory Syncytial Virus (RSV) Illness [NA]
Clinical trial evaluating a single IV dose of motavizumab for RSV illness in infants ≤12 months; study completed with results posted.